The mission of The PolG Foundation is to support and accelerate research to find effective treatments and a cure for PolG-related mitochondrial disorders.
Excellent Bologna workshop on DNA polymerase gamma diseases, organized and facilitated by the new vibrant @PolGFoundation. Action plans, brainstorms. A stimulating global effort to make a difference for the devastating disease group. #mitochondrialdisease#ResearchBringsHope
Our Founder, Julie de Luxembourg, interviewed by @4Lilyfoundation on their partnership and the importance of collaboration to drive research forward.
https://t.co/K6Zcp9f9dD
What an inspirational, comprehensive, mission-driven @PolGFoundation board meeting. For patients with #mitochondrialdisease & #polg-we won’t stop until we find better treatments & cures. Check out https://t.co/Dq28ip5Qz1 for our research grant program happening now!! #MedTwitter
The @PolGFoundation 2023 research call is open. The Foundation seeks to fund research projects of up to $250.000 p/y (max 5 year research projects) that will have direct impact on drug discovery and clinical development of PolG therapeutics. Full details: https://t.co/Aea6Y178Zy
The mission of The PolG Foundation is to support and accelerate research to find effective treatments and a cure for PolG mitochondrial disorders.
To advance this mission, we are announcing our first Call for Proposals.
https://t.co/rghw8eJpS9
#polg#mitochondrialdisease
The @PolGFoundation 2023 research call is open. The Foundation seeks to fund research projects of up to $250.000 p/y (max 5 year research projects) that will have direct impact on drug discovery and clinical development of PolG therapeutics. Full details: https://t.co/Aea6Y0PxAY
Very proud to see our latest story and my art work in the cover of @Cell_Metabolism picturing the damaged, leaky #mitochondria due to oxidative stress and #ferroptosis
https://t.co/uugGxUNXYU
Can we just take a moment to appreciate how crazy cool this is?
Dietary lipids inhibit mitochondria transfer to macrophages to divert adipocyte-derived mitochondria into the blood
https://t.co/Ek5luQMu97
Hello from The PolG Foundation!
Our story starts with the journey of one family and, more particularly, one young man, Frederik. Inspired by Frederik's example of sheer determination, they set out to transform hardship into deep resolve and find a cure for a devastating disease.
The disease comes from a mutation in POLG and POLG2 genes. These mutations impair efficient replication of the mitochondria DNA, causing symptoms that can start from early childhood to adulthood. Symptoms often include ophthalmoplegia, muscle weakness, epilepsy and liver failure.
We already have a few ongoing research projects.
Mouse model 1, Generating and investigating in vivo PolG mouse models to unravel the mechanistic pathogenesis of PolG disorders.
Mouse Model 2, Development and preclinical validation in mice of gene therapy treatment.
Happy to have played a small part in the Acipimox Trial @MitoResearch the design of which has just been published in Trials https://t.co/FDYLUzNNYy
#mitoaware@mitomusclelab@jwmdrc